![Brigham Doc's NEJM Paper Decries Morcellation's Demise—Did She Get Confidential Patient Information?](https://cdn.cancerletter.com/media/2016/03/22035146/42-11-hype.jpg)
![Brigham Doc's NEJM Paper Decries Morcellation's Demise—Did She Get Confidential Patient Information?](https://cdn.cancerletter.com/media/2016/03/22035146/42-11-hype.jpg)
Cover Story
Free
Brigham Doc's NEJM Paper Decries Morcellation's Demise—Did She Get Confidential Patient Information?
By Matthew Bin Han Ong
Update: The New England Journal of Medicine's subsequent response after this article is published is appended at the end.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Drugs & Targets
Trending Stories
- Federal judge blocks Trump administration’s move to limit indirect costs to 15% for NIH-funded institutions
The move could gut academic cancer research - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - “Page Not Found:” HHS agencies purge web pages that hint at DEI, health equity, and gender
Medical group sues over removing “information used every day by health professions” - Beyond the $500B Stargate Project: The frontier of AI in oncology beckons
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills